GI
KIDS icon

GAMMA Investing’s OrthoPediatrics KIDS Stock Holding History

GAMMA Investing’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1K Buy
684
+37
+6% +$643 ﹤0.01% 3067
2026
Q1 		$10.3K Buy
647
+342
+112% +$5.97K ﹤0.01% 3057
2025
Q4 		$5.42K Buy
305
+225
+281% +$3.94K ﹤0.01% 3241
2025
Q3 		$1.48K Buy
80
+25
+45% +$515 ﹤0.01% 3525
2025
Q2 		$1.18K Sell
55
-376
-87% -$8.13K ﹤0.01% 3508
2025
Q1 		$10.6K Buy
431
+206
+92% +$5.09K ﹤0.01% 2719
2024
Q4 		$5.22K Buy
225
+53
+31% +$1.32K ﹤0.01% 2904
2024
Q3 		$4.66K Buy
172
+8
+5% +$242 ﹤0.01% 2769
2024
Q2 		$4.72K Sell
164
-104
-39% -$3.19K ﹤0.01% 2602
2024
Q1 		$7.82K Buy
268
+43
+19% +$1.2K ﹤0.01% 2183
2023
Q4 		$5.88K Buy
+225
New +$6.52K ﹤0.01% 2161

Other funds holding KIDS

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

GAMMA Investing's KIDS Position: Q2 2026 in Review

GAMMA Investing increased its OrthoPediatrics (KIDS) stake by 5.7% in Q2 2026, buying an estimated $643 and bringing the position to 684 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3067.

GAMMA Investing first reported a position in KIDS in Q4 2023 and has held it in 11 quarters since. 5 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.

  • GAMMA Investing held 684 shares of OrthoPediatrics worth $13.1K as of Q2 2026.
  • GAMMA Investing bought 37 OrthoPediatrics shares in Q2 2026, an estimated $643.
  • OrthoPediatrics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3067 holding.
  • GAMMA Investing first reported a position in OrthoPediatrics in Q4 2023 and has held it in 11 quarters since.
  • 5 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.